Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor

被引：2
|
作者：
Koch, Richard A. [1 ]
Clark, Richard F. [1 ]
机构：
[1] Univ Calif San Diego, Dept Emergency Med, Div Med Toxicol, San Diego, CA 92103 USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2018年 / 25卷 / 05期
关键词：
SGLT2; INHIBITORS;
D O I：
10.1097/MJT.0000000000000602
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E590 / E591
页数：3
相关论文
共 50 条
  • [41] Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter 2 Inhibitor Use in Two Patients Undergoing Pancreatectomy
    Pace, Devon J.
    Dukleska, Katerina
    Phillips, Samantha
    Gleason, Vanessa
    Yeo, Charles J.
    JOURNAL OF PANCREATIC CANCER, 2018, 4 (01): : 95 - 99
  • [42] Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report
    Abrar Alkatheeri
    Eiman Alseddeeqi
    Journal of Medical Case Reports, 16
  • [43] Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition
    Peters, Anne L.
    Buschur, Elizabeth O.
    Buse, John B.
    Cohan, Pejman
    Diner, Jamie C.
    Hirsch, Irl B.
    DIABETES CARE, 2015, 38 (09) : 1687 - 1693
  • [44] Postcardiac Surgery Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Cotransporter 2 Inhibitors
    Auerbach, Jonathan S.
    Gershengorn, Hayley B.
    Aljure, Oscar D.
    Lamelas, Joseph
    Patel, Samira S.
    Ferreira, Tanira D.
    Gonzalez, Lazaro A.
    Cabrera, Jorge L.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2023, 37 (06) : 956 - 963
  • [45] Stress cardiomyopathy and euglycemic ketoacidosis in a patient treated with sodium-glucose cotransporter type 2
    Wang, Zisong
    Zhao, Peiyi
    Springer, Tom
    Zhu, Congyi
    Mau, Jaccob
    Wells, Andrew
    Xia, Yinshui
    Wang, Lingli
    IEEE TRANSACTIONS ON VERY LARGE SCALE INTEGRATION (VLSI) SYSTEMS, 2023, 31 (05) : 706 - 710
  • [46] Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports
    Khedr, Anwar
    Hennawi, Hussam Al
    Khan, Muhammed Khuzzaim
    Eissa, Aalaa
    Mir, Mikael
    Rauf, Ibtisam
    Nitesh, Jain
    Surani, Salim
    Khan, Syed Anjum
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (24) : 5700 - 5709
  • [47] EUGLYCEMIC DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES MELLITUS ON SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS INDUCED BY COVID-19
    AlSaraj, Fuad
    Krishnareddy, Kalpana
    Capatos, Gerasmos
    Medhat, Paula
    MEDICINE, 2021, 100 (33)
  • [48] An Age of Sodium-Glucose Cotransporter-2 Inhibitor Priority: Are We Ready?
    Seo, Ji A.
    DIABETES & METABOLISM JOURNAL, 2019, 43 (05) : 578 - 581
  • [49] Implementing Sodium-Glucose Cotransporter-2 Inhibitor Therapy for Heart Failure
    Nassif, Michael E.
    Januzzi, James L., Jr.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (19) : 1785 - 1787
  • [50] The Impact of a Passive Alert on Screening for Euglycemic Diabetic Ketoacidosis in Hospitalized Patients Using an Sodium-Glucose Cotransporter 2 Inhibitor
    Soliman, Diana
    Musser, R. Clayton
    Jackson, Jason P.
    German, Jashalynn
    Carlson, Scott
    Odonnell, Kathryn H.
    Setji, Tracy
    DIABETES, 2022, 71
12345